Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2012 May 8;84(2):e187–e193. doi: 10.1016/j.ijrobp.2012.03.030

Table 1.

Patient characteristics, FSFI scores, and univariate results

Covariate Level No. of patients (%) Mean FSFI (±SD)* Univariate P value
Age group (y) <50 6 (5.8)   19.8 (12.2)   .096
50–59 21 (20.2)   14.3 (10.3)
60–69 44 (42.3)   15.0 (11.2)
70–79 24 (23.1) 10.9 (9.6)
80+ 9 (8.7)   12.2 (10.1)
Racial group White 83 (79.8)   14.3 (10.6)   .599
Black/African-American 7 (6.7) 10.5 (9.3)
Hispanic 6 (5.8)     9.2 (11.2)
Asian 4 (3.8)   16.6 (14.6)
Other 4 (3.8)   18.0 (11.8)
Marital status Married 63 (60.6)   14.3 (10.4)   .683
Divorced 8 (7.7)   12.5 (11.3)
Single 18 (17.3)   11.3 (10.4)
Widowed 9 (8.7)   15.3 (12.8)
Other 6 (5.8)   18.0 (11.5)
Education level No degree 3 (2.9)   3.7 (2.2)   .359
High school degree 28 (27.2)   13.4 (10.7)
College degree 32 (31.1)   15.2 (11.4)
Postgraduate degree 40 (38.8)   14.2 (10.4)
Diabetes No 86 (82.7)   14.6 (10.7)   .146
Yes 18 (17.3)   10.6 (10.3)
High bp No 63 (60.6)   15.2 (11.3)   .137
Yes 41 (39.4) 12.0 (9.5)
Anxiety No 87 (83.7)   14.4 (10.8)   .319
Yes 17 (16.3) 11.6 (9.7)
Karnofsky performance score 80 or less 10 (9.6)   9.4 (6.2)   .159
90 or 100 94 (90.4)   14.4 (10.9)
Time from hysterectomy (binary) <6 mo 25 (24.3) 12.2 (9.9)   .325
≥6 mo 78 (75.7)   14.7 (10.9)
Time from hysterectomy <6 mo 25 (24.3) 12.2 (9.9)   .816
6 mo–1 y 10 (9.7)   17.1 (12.0)
1–2 y 15 (14.6)   16.0 (10.4)
2–3 y 9 (8.7)   16.5 (12.6)
3–4 y 14 (13.6)   14.4 (10.1)
4–5 y 10 (9.7)   13.4 (11.6)
>5 y 20 (19.4)   12.4 (10.9)
Hysterectomy type Laparotomy 45 (45.9) 10.3 (9.7) <.001
Minimally invasive surgery 53 (54.1)   17.8 (10.5)
Ever use vaginal dilator No 25 (24.3)   12.3 (11.1)   .346
Yes 78 (75.7)   14.6 (10.5)
Lubricant use since hysterectomy No 68 (65.4)   11.7 (10.7)   .002
Yes 36 (34.6) 18.2 (9.2)
Vaginal moisturizer use since hysterectomy No 72 (69.2)   14.1 (10.8)   .794
Yes 32 (30.8)   13.5 (10.6)
Topical estrogen use since hysterectomy No 96 (92.3)   14.0 (10.7)   .989
Yes 8 (7.7)   13.9 (10.4)

Abbreviation: bp = blood pressure; FSFI = Female Sexual Function Index; SD = standard deviation.

*

Mean values reflect the FSFI according to each patient characteristic.

P value represents an association between each covariate with FSFI score as a continuous variable.